Benchtop NMR for streamlined quality control of PLGA and synthetic copolymers

Poly(lactide-co-glycolide) copolymers (PLGAs) are biodegradable, biocompatible synthetic materials widely used across pharmaceutical applications. Derived from lactic and glycolic acids, these copolymers break down into non-toxic metabolites, making them particularly well-suited for drug delivery systems and resorbable implants.

One of PLGA's key advantages lies in the precise control over composition and microstructure during manufacturing, allowing their properties to be finely tuned for specific therapeutic needs. However, the broad diversity of PLGA-based materials also presents challenges in ensuring consistent quality. Variability in polymer structure can directly impact performance and safety, making reliable characterization essential.

Despite their established use in many approved drug products, PLGAs have only recently been included in major pharmacopeias, and even then, only a limited number of variants are covered.

Download the full whitepaper here.

About Bruker BioSpin - NMR, EPR and Imaging - Pharma

Welcome to Bruker BioSpin and the world's most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develop, manufacture and supply technology to research establishments, commercial enterprises and multi-national corporations across countless industries and fields of expertise.

Bruker BioSpin is continuing to revolutionize the design, manufacture and distribution of life science, preclinical, process control and analytical research tools based on magnetic resonance and multimodal imaging technologies. Bruker BioSpin is the worldwide technology and market leader in magnetic resonance technologies (NMR, EPR) and offers the largest portfolio of imaging modalities for preclinical and industrial research under a single brand.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Oct 8, 2025 at 11:17 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker BioSpin - NMR, EPR and Imaging - Pharma. (2025, October 08). Benchtop NMR for streamlined quality control of PLGA and synthetic copolymers. News-Medical. Retrieved on October 08, 2025 from https://www.news-medical.net/whitepaper/20251008/Benchtop-NMR-for-streamlined-quality-control-of-PLGA-and-synthetic-copolymers.aspx.

  • MLA

    Bruker BioSpin - NMR, EPR and Imaging - Pharma. "Benchtop NMR for streamlined quality control of PLGA and synthetic copolymers". News-Medical. 08 October 2025. <https://www.news-medical.net/whitepaper/20251008/Benchtop-NMR-for-streamlined-quality-control-of-PLGA-and-synthetic-copolymers.aspx>.

  • Chicago

    Bruker BioSpin - NMR, EPR and Imaging - Pharma. "Benchtop NMR for streamlined quality control of PLGA and synthetic copolymers". News-Medical. https://www.news-medical.net/whitepaper/20251008/Benchtop-NMR-for-streamlined-quality-control-of-PLGA-and-synthetic-copolymers.aspx. (accessed October 08, 2025).

  • Harvard

    Bruker BioSpin - NMR, EPR and Imaging - Pharma. 2025. Benchtop NMR for streamlined quality control of PLGA and synthetic copolymers. News-Medical, viewed 08 October 2025, https://www.news-medical.net/whitepaper/20251008/Benchtop-NMR-for-streamlined-quality-control-of-PLGA-and-synthetic-copolymers.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.